Clinical Trial Update: Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update of toripalimab as monotherapy for Small Cell Carcinoma of the Esophagus in patients who failed chemotherapy; the current trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Carcinoma of Esophagus

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Small Cell Carcinoma of Esophagus, Advanced Cancer | Phase 2 | Status: UNKNOWN